Results From Phase 2 Trial Ongoing Expansion Stage of SL-401 in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). ASH 2016
Results from Phase 2 Trial Ongoing Expansion Stage of SL-401 in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). ASH 2016. Clinical – Oral Presentation
